Vanguard Group Inc Bio Cardia, Inc. Call Options Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding BCDA
# of Institutions
24Shares Held
1.95MCall Options Held
17.2KPut Options Held
0-
Cm Management, LLC700KShares$2.09 Million0.25% of portfolio
-
Geode Capital Management, LLC Boston, MA156KShares$466,0180.0% of portfolio
-
Two Sigma Securities, LLC New York, NY111KShares$332,1260.0% of portfolio
-
Family Management Corp New York, NY77.5KShares$231,7250.01% of portfolio
-
Black Rock Inc. New York, NY45.9KShares$137,2140.0% of portfolio
About BioCardia, Inc.
- Ticker BCDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,758,200
- Market Cap $53.1M
- Description
- BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. Its lead therapeutic candidate is the CardiAMP Cell Therapy System for the treatment of heart failure and chronic myocardial ischemia; and allogeneic cell therapy for cardiac and pulmonary di...